| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Molecular and Cellular Biology, BaylorCollege of Medicine, Houston, Texas
Mice lacking the intermediate filament protein desmin demonstrate abnormal mitochondria behavior, disruption of muscle architecture, and myocardial degeneration with extensive calcium deposits and fibrosis. These abnormalities are associated with cardiomyocyte hypertrophy, cardiac chamber dilation and eventually with heart failure. In an effort to elucidate the molecular mechanisms leading to the observed pathogenesis, we have analyzed gene expression changes in cardiac tissue using differential display polymerase chain reaction and cDNA atlas array methods. The most substantial changes were found in genes coding the small extracellular matrix proteins osteopontin and decorin that are dramatically induced in the desmin-null myocardium. We further analyzed their expression pattern both at the RNA and protein levels and we compared their spatial expression with the onset of calcification. Extensive osteopontin localization is observed by immunohistochemistry in the desmin-null myocardium in areas with massive myocyte death, as well as in hypercellular regions with variable degrees of calcification and fibrosis. Osteopontin is consistently co-localized with calcified deposits, which progressively are transformed to psammoma bodies surrounded by decorin, especially in the right ventricle. These data together with the observed up-regulation of transforming growth factor-ß1 and angiotensin-converting enzyme, could explain the extensive fibrosis and dystrophic calcification observed in the heart of desmin-null mice, potentially crucial events leading to heart failure.
Related articles in Am J Pathol:
This article has been cited by other articles:
 |
|
 |
|
  M. Mavroidis, P. Panagopoulou, I. Kostavasili, N. Weisleder, and Y. Capetanaki A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization FASEB J, September 1, 2008; 22(9): 3318 - 3327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Lieber, H. Qiu, L. Chen, Y.-T. Shen, C. Hong, W. C. Hunter, N. Aubry, S. F. Vatner, and D. E. Vatner Cardiac dysfunction in aging conscious rats: altered cardiac cytoskeletal proteins as a potential mechanism Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H860 - H866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Hashemi, S. Ghods, F. D. Kolodgie, K. Parcham-Azad, M. Keane, D. Hamamdzic, R. Young, M. K. Rippy, R. Virmani, H. Litt, et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction Eur. Heart J., January 2, 2008; 29(2): 251 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Korff, F. Schoensiegel, N. Riechert, D. Weichenhan, H. A. Katus, and B. T. Ivandic Fine mapping of Dyscalc1, the major genetic determinant of dystrophic cardiac calcification in mice. Physiol Genomics, May 16, 2006; 25(3): 387 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Balogh, Z. Li, D. Paulin, and A. Arner Desmin Filaments Influence Myofilament Spacing and Lateral Compliance of Slow Skeletal Muscle Fibers Biophys. J., February 1, 2005; 88(2): 1156 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Aherrahrou, S. B. Axtner, P. M. Kaczmarek, A. Jurat, S. Korff, L. C. Doehring, D. Weichenhan, H. A. Katus, and B. T. Ivandic A Locus on Chromosome 7 Determines Dramatic Up-Regulation of Osteopontin in Dystrophic Cardiac Calcification in Mice Am. J. Pathol., April 1, 2004; 164(4): 1379 - 1387. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
